Self-Renewal of Macrophages: Tumor-Released Factors and Signaling Pathways.
metabolic signature
proliferation
self-renewal
signaling pathways
tumor-associated macrophages
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
26 Oct 2022
26 Oct 2022
Historique:
received:
20
09
2022
revised:
14
10
2022
accepted:
21
10
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
12
11
2022
Statut:
epublish
Résumé
Macrophages are the most abundant immune cells of the tumor microenvironment (TME) and have multiple important functions in cancer. During tumor growth, both tissue-resident macrophages and newly recruited monocyte-derived macrophages can give rise to tumor-associated macrophages (TAMs), which have been associated with poor prognosis in most cancers. Compelling evidence indicate that the high degree of plasticity of macrophages and their ability to self-renew majorly impact tumor progression and resistance to therapy. In addition, the microenvironmental factors largely affect the metabolism of macrophages and may have a major influence on TAMs proliferation and subsets functions. Thus, understanding the signaling pathways regulating TAMs self-renewal capacity may help to identify promising targets for the development of novel anticancer agents. In this review, we focus on the environmental factors that promote the capacity of macrophages to self-renew and the molecular mechanisms that govern TAMs proliferation. We also highlight the impact of tumor-derived factors on macrophages metabolism and how distinct metabolic pathways affect macrophage self-renewal.
Identifiants
pubmed: 36359228
pii: biomedicines10112709
doi: 10.3390/biomedicines10112709
pmc: PMC9687165
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Science. 2014 May 23;344(6186):921-5
pubmed: 24812208
Cell Metab. 2014 Jan 7;19(1):162-171
pubmed: 24374218
Nat Immunol. 2016 Feb;17(2):159-68
pubmed: 26642357
Cell Rep. 2019 Jul 2;28(1):218-230.e7
pubmed: 31269442
Nat Immunol. 2009 Jul;10(7):734-43
pubmed: 19503107
J Immunol. 2017 Jan 1;198(1):492-504
pubmed: 27881705
Clin Chem Lab Med. 2004 Mar;42(3):256-60
pubmed: 15080556
Nat Commun. 2013;4:1886
pubmed: 23695680
Immunity. 2013 Apr 18;38(4):792-804
pubmed: 23601688
Annu Rev Immunol. 1997;15:323-50
pubmed: 9143691
Biotherapy. 1992;4(4):267-76
pubmed: 1622740
Mol Neurodegener. 2015 Sep 04;10:43
pubmed: 26337043
Cancer Res. 2020 Aug 15;80(16):3319-3330
pubmed: 32561530
Am J Cancer Res. 2014 Jan 15;4(1):61-72
pubmed: 24482739
Cancer Res. 2014 Sep 15;74(18):5057-69
pubmed: 25082815
J Clin Invest. 2017 Jan 3;127(1):14-23
pubmed: 28045399
Annu Rev Pathol. 2020 Jan 24;15:123-147
pubmed: 31530089
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
Elife. 2016 Feb 19;5:
pubmed: 26894960
Nat Rev Neurol. 2018 Nov;14(11):667-675
pubmed: 30266932
Nat Commun. 2016 Jan 27;7:10321
pubmed: 26813785
Cell Death Discov. 2020 Jul 23;6:63
pubmed: 32714570
Immunity. 2013 Jan 24;38(1):79-91
pubmed: 23273845
Immunity. 2015 Mar 17;42(3):419-30
pubmed: 25786174
Int J Mol Med. 2015 Jan;35(1):92-102
pubmed: 25395235
Diabetes Care. 2008 Feb;31 Suppl 2:S161-4
pubmed: 18227479
Cell. 2020 Aug 20;182(4):796-798
pubmed: 32822571
Purinergic Signal. 2020 Sep;16(3):289-295
pubmed: 32529478
Elife. 2018 May 14;7:
pubmed: 29757143
Immunity. 2020 Jun 16;52(6):957-970
pubmed: 32553181
Trends Immunol. 2022 Jul;43(7):546-563
pubmed: 35690521
Nat Commun. 2013;4:2834
pubmed: 24280772
Cell. 2017 Feb 9;168(4):657-669
pubmed: 28187287
J Immunol. 2019 Dec 15;203(12):3447-3460
pubmed: 31704881
J Biol Chem. 2007 Jun 29;282(26):18980-90
pubmed: 17420255
Nature. 2013 Apr 11;496(7444):238-42
pubmed: 23535595
Cell Metab. 2019 Feb 5;29(2):457-474.e5
pubmed: 30595478
Histopathology. 2008 Jul;53(1):30-8
pubmed: 18510570
J Clin Invest. 2019 May 20;129(7):2619-2628
pubmed: 31107246
Hepatology. 2014 Dec;60(6):1879-90
pubmed: 25066464
J Exp Med. 1968 Sep 1;128(3):415-35
pubmed: 5666958
Nat Rev Clin Oncol. 2017 Jul;14(7):399-416
pubmed: 28117416
Science. 2012 Apr 6;336(6077):86-90
pubmed: 22442384
Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):E2191-8
pubmed: 23708119
J Cancer. 2021 Oct 17;12(23):7111-7119
pubmed: 34729112
Pediatr Rheumatol Online J. 2016 Sep 08;14(1):51
pubmed: 27609179
Int J Cancer. 2015 Jul 15;137(2):278-88
pubmed: 25477239
J Leukoc Biol. 1984 Jun;35(6):561-72
pubmed: 6586941
J Immunol. 1990 Mar 15;144(6):2409-12
pubmed: 2138198
J Immunother Cancer. 2017 Jul 18;5(1):53
pubmed: 28716061
Cells. 2019 Dec 23;9(1):
pubmed: 31878087
Elife. 2022 Feb 14;11:
pubmed: 35156921
Nat Commun. 2021 Nov 25;12(1):6867
pubmed: 34824203
Science. 2013 Nov 22;342(6161):1242974
pubmed: 24264994
FEBS J. 2018 Feb;285(4):680-699
pubmed: 29171156
EMBO J. 2019 Oct 1;38(19):e101233
pubmed: 31414712
Immunity. 2012 Dec 14;37(6):1050-1060
pubmed: 23177320
Clin Cancer Res. 2020 Jun 1;26(11):2640-2653
pubmed: 32060101
J Leukoc Biol. 2007 Mar;81(3):711-9
pubmed: 17158607
Science. 2009 Nov 6;326(5954):867-71
pubmed: 19892988
Clin Chem Lab Med. 2003 May;41(5):646-51
pubmed: 12812262
Front Immunol. 2019 Jul 03;10:1462
pubmed: 31333642
J Immunol. 2021 Feb 1;206(3):621-630
pubmed: 33443065
Science. 2014 May 9;344(6184):645-648
pubmed: 24762537
Cancer Res. 2010 Jul 15;70(14):5728-39
pubmed: 20570887
Cell. 2006 Jan 27;124(2):263-6
pubmed: 16439202
Immunity. 2017 Aug 15;47(2):323-338.e6
pubmed: 28813661
Cell Mol Life Sci. 2017 Jul;74(14):2569-2586
pubmed: 28258292
Curr Opin Pharmacol. 2020 Aug;53:134-145
pubmed: 33022543
Ann Transl Med. 2020 Aug;8(16):1030
pubmed: 32953830
Int Immunopharmacol. 2020 Jun;83:106432
pubmed: 32248017
Immunity. 2016 Oct 18;45(4):817-830
pubmed: 27760338
Mol Ther Oncolytics. 2022 Feb 22;24:799-813
pubmed: 35317518
Cell Tissue Res. 2019 Oct;378(1):81-96
pubmed: 31011801
Nat Commun. 2018 Feb 8;9(1):582
pubmed: 29422500
J Leukoc Biol. 2010 Aug;88(2):279-90
pubmed: 20453107
J Exp Med. 2015 May 4;212(5):681-97
pubmed: 25897174
Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):1564-9
pubmed: 26811453
Nat Commun. 2020 May 8;11(1):2285
pubmed: 32385277
Mitochondrion. 2022 Jan;62:85-101
pubmed: 34740864
Science. 2011 Jun 10;332(6035):1284-8
pubmed: 21566158
Cancer Res. 2016 Oct 15;76(20):6030-6042
pubmed: 27550451
FEBS J. 2022 Jul;289(13):3735-3751
pubmed: 35066977
Cancer Lett. 2008 Aug 28;267(2):204-15
pubmed: 18448242
Cell Metab. 2006 Jul;4(1):13-24
pubmed: 16814729
Science. 2016 Feb 12;351(6274):aad5510
pubmed: 26797145
Nat Med. 2013 Oct;19(10):1264-72
pubmed: 24056773
J Immunol. 2019 May 1;202(9):2700-2709
pubmed: 30867240
Cell Metab. 2019 Jun 4;29(6):1376-1389.e4
pubmed: 30930171
Arthritis Res Ther. 2019 Jan 7;21(1):9
pubmed: 30616678
Nat Rev Immunol. 2014 Jun;14(6):392-404
pubmed: 24854589
J Hematol Oncol. 2022 Aug 28;15(1):118
pubmed: 36031601
Biomedicines. 2021 Oct 04;9(10):
pubmed: 34680504
J Exp Med. 2003 Aug 18;198(4):645-51
pubmed: 12913093
Sci Rep. 2018 Jan 11;8(1):418
pubmed: 29323162
Nat Commun. 2018 Jan 2;9(1):21
pubmed: 29295986
Immunity. 2021 Jun 8;54(6):1200-1218.e9
pubmed: 33951416
J Exp Med. 2018 Oct 1;215(10):2536-2553
pubmed: 30201786
Front Immunol. 2019 Sep 04;10:2019
pubmed: 31552020
Cancer Sci. 2014 Jan;105(1):1-8
pubmed: 24168081
Sci Rep. 2017 Mar 20;7:44270
pubmed: 28317921
Semin Immunol. 2015 Aug;27(4):286-96
pubmed: 26360589
Crit Rev Immunol. 2012;32(6):463-88
pubmed: 23428224
FEBS J. 2021 Jun;288(12):3694-3714
pubmed: 33460504
Tumour Biol. 2003 Sep-Oct;24(5):236-40
pubmed: 15001836
Nat Commun. 2016 Jun 13;7:ncomms11852
pubmed: 27292029
J Pathol. 2010 May;221(1):77-86
pubmed: 20191615
Nat Immunol. 2014 Sep;15(9):846-55
pubmed: 25086775
J Immunother Cancer. 2016 Aug 16;4:49
pubmed: 27532024
Nat Immunol. 2019 Jun;20(6):687-700
pubmed: 31061528
Am J Reprod Immunol. 2020 Aug;84(2):e13261
pubmed: 32356306
J Transl Med. 2021 Oct 30;19(1):454
pubmed: 34717685
J Biol Chem. 2000 Mar 10;275(10):7403-9
pubmed: 10702314
Cell Metab. 2017 Jul 5;26(1):49-70
pubmed: 28683294
J Biol Chem. 2016 Feb 19;291(8):3932-46
pubmed: 26679997
Annu Rev Pathol. 2011;6:275-97
pubmed: 21034223
Cell Res. 2015 Jul;25(7):771-84
pubmed: 26045163
Diabetologia. 2014 Mar;57(3):491-501
pubmed: 24429578
Anticancer Res. 2015 Feb;35(2):865-74
pubmed: 25667468
Cell Rep. 2021 Jun 15;35(11):109264
pubmed: 34133930
Cell Rep. 2021 Dec 21;37(12):110132
pubmed: 34936871
Blood. 1991 Feb 1;77(3):616-27
pubmed: 1846764
Cell. 2020 Aug 20;182(4):872-885.e19
pubmed: 32783915
J Clin Med. 2021 Mar 17;10(6):
pubmed: 33802948
Cell Biol Int. 2021 Apr;45(4):890-897
pubmed: 33289218
Front Bioeng Biotechnol. 2021 Apr 20;9:644648
pubmed: 33959597
Mol Metab. 2016 Sep 13;5(11):1131-1137
pubmed: 27818939
Stem Cell Reports. 2017 Feb 14;8(2):334-345
pubmed: 28111278
Biomark Res. 2021 Jan 6;9(1):1
pubmed: 33407885
Int J Cell Biol. 2012;2012:501962
pubmed: 22505929
Cell Rep. 2019 Jul 9;28(2):498-511.e5
pubmed: 31291584
Biochim Biophys Acta. 2001 May 28;1539(1-2):140-6
pubmed: 11389976
Mediators Inflamm. 2017;2017:9029327
pubmed: 29386753
Curr Opin Immunol. 2006 Feb;18(1):49-53
pubmed: 16338128
Life Sci Alliance. 2021 Mar 29;4(6):
pubmed: 33782087
Nat Immunol. 2012 Jun 24;13(8):753-60
pubmed: 22729249
Oncogene. 2021 Jan;40(2):355-368
pubmed: 33144684
J Hepatol. 2021 Mar;74(3):627-637
pubmed: 33137360
Nat Immunol. 2006 Mar;7(3):265-73
pubmed: 16444257
Breast Cancer Res Treat. 2011 Aug;128(3):703-711
pubmed: 20842526
Infect Drug Resist. 2019 Aug 22;12:2589-2611
pubmed: 31686866
Oncoimmunology. 2016 Jan 4;5(4):e1122157
pubmed: 27141406
Trends Immunol. 2019 Apr;40(4):310-327
pubmed: 30890304
Cell Death Dis. 2016 Mar 31;7:e2167
pubmed: 27031964
Oncol Lett. 2020 Nov;20(5):234
pubmed: 32968456
J Immunol. 2017 Apr 1;198(7):2927-2934
pubmed: 28193830
EMBO J. 2017 Aug 15;36(16):2353-2372
pubmed: 28701484
Cell Metab. 2016 Nov 8;24(5):701-715
pubmed: 27773694
Eur J Immunol. 1995 Apr;25(4):1101-4
pubmed: 7537672
Cell. 2020 Aug 20;182(4):886-900.e17
pubmed: 32783918
Cells. 2018 Aug 09;7(8):
pubmed: 30096862
Cancer Lett. 2019 Jun 28;452:14-22
pubmed: 30905817
Immunity. 2021 Aug 10;54(8):1883-1900.e5
pubmed: 34331874
Int J Oncol. 2016 Nov;49(5):2064-2074
pubmed: 27599777
Cell Rep. 2016 Nov 22;17(9):2445-2459
pubmed: 27840052
Ann N Y Acad Sci. 2021 Sep;1499(1):18-41
pubmed: 32445205
J Immunol. 2008 Mar 15;180(6):4166-72
pubmed: 18322228
Trends Immunol. 2019 Feb;40(2):98-112
pubmed: 30579704
J Exp Med. 2017 Mar 6;214(3):597-607
pubmed: 28209725
Mol Cell. 2008 Aug 8;31(3):422-31
pubmed: 18691974
Cell Microbiol. 2016 Apr;18(4):475-87
pubmed: 26880038
Int J Mol Sci. 2021 Apr 05;22(7):
pubmed: 33916440
Cancer Cell. 2014 Jun 16;25(6):846-59
pubmed: 24898549
PLoS One. 2015 Oct 07;10(10):e0140064
pubmed: 26445168
Nat Rev Endocrinol. 2020 Feb;16(2):81-90
pubmed: 31836875
Cancer Immunol Immunother. 2022 Oct;71(10):2511-2522
pubmed: 35278107
J Immunother Cancer. 2020 Jun;8(1):
pubmed: 32581053
Trends Pharmacol Sci. 2020 Oct;41(10):701-714
pubmed: 32946772
Immunity. 2019 May 21;50(5):1317-1334.e10
pubmed: 30979687
Front Immunol. 2021 Apr 22;12:629281
pubmed: 33968022
Immunity. 2011 Dec 23;35(6):871-82
pubmed: 22195744
Front Immunol. 2019 Jul 31;10:1799
pubmed: 31417566
Cell Metab. 2018 Sep 4;28(3):463-475.e4
pubmed: 30184486
Annu Rev Nutr. 2002;22:87-105
pubmed: 12055339
Eur J Immunol. 2014 Aug;44(8):2247-62
pubmed: 24796276